AIM To determine the long term efficacy of monotherapy with topically applied β blocking
agents and to determine whether selective β blockers were able to preserve the visual field …

This open study of beta blockers in chronic simple glaucoma compared the efficacy of once
daily (od) oral nadolol therapy with twice daily (bd) topical timolol therapy. Sixty eight …

Br J Ophthalmol: first published as 10.1136/bjo. 86.6. 691 on 1 June 2002. Downloaded
from more potent than dipivefrin and less likely to provoke surface discomfort or allergic …

We reported earlier on a prospective, randomized, double-masked study in which 36
patients with open-angle glaucoma were treated with either 0.5% betaxolol or 0.5% timolol …

Topical β-blockers reduce the intraocular pressure (IOP) by blockade of sympathetic nerve
endings in the ciliary epithelium causing a fall in aqueous humour production. Two types of …

The intraocular pressure (IOP) lowering efficacy of once-daily levobunolol 0.5% was
compared with timolol 0.5% twice-daily and timolol 0.5% once-daily in 20 chronic open …

In a prospective, randomized, double-masked study, 44 patients with primary open-angle
glaucoma were treated either with 0.5% betaxolol or 0.5% timolol in both eyes twice daily …

In the twenty years since beta-blockers were proposed for treatment of glaucoma, use of
topical timolol has increased to account for 70% of all glaucoma medications used. The …

In a prospective, randomized study, nineteen patients with ocular hypertension (n= 14) or
chronic open-angle glaucoma (n= 5) were treated with either betaxolol 0.5% or timolol 0.5 …

• Betaxolol hydrochloride is a topical β 1-blocking agent that has been found to be safe and
effective in lowering intraocular pressure (IOP) in patients with glaucoma. We administered …